Ipamorelin is a selective GH-Secretagogue and ghrelin receptor agonist. The potency of ghrelin stimulation can be compared to GHRP6 with less appetite stimulation properties.
However, unlike other GH-Secretagogues this pentapeptide doesn’t release the same volumes of cortisol, acetylcholine, prolactin and aldosterone.
It is for this reason Ipamorelin has been considered the first selective, and best, GH Secretagogue.
Growth Hormone-Releasing Peptide 2mg/vial
Inject a minimum of 200mcg subcutaneously once daily 5 out of 7 days of the week.
We recommend using the Ipamorelin in combination with CJC 1295 as it provides a synergistic effect, generating five times the benefits of using the CJC 1295 or Ipamorelin alone. The combination allows for maximized release of GH because the CJC 1295 and Ipamorelin have different mechanisms of action and work on different receptors (GHRH-R & Ghrelin-R).